Big news: our prices just got a lot lower. Shop now|New here? Get up to $200 in welcome perks, valid for 14 days. Claim offer now
US shipping INCLUDED on orders above $200
Research Insights

All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.

PTD-DBM and Wnt/β-Catenin Signaling in Hair-Follicle Research Models

Tyler Hayes
October 28, 2026
PTD-DBM and Wnt/β-Catenin Signaling in Hair-Follicle Research Models

Brief Overview/Summary

An overview of published laboratory research on PTD-DBM, a synthetic peptide that blocks the interaction between CXXC5 and Dishevelled, and its effects on Wnt/β-catenin signaling in cell and mouse hair-follicle models.

This overview summarizes published laboratory research on PTD-DBM, a synthetic peptide that has been studied in cell-signaling, wound-healing and hair-follicle models.

Hair-follicle biology is an active area of laboratory research, and much of that work focuses on the cell-signaling pathways that regulate how follicles form, cycle and regenerate, including the Wnt/β-catenin pathway. PTD-DBM was developed as a tool for modulating this pathway.

The studies described below were carried out in cultured cells and in mice. PTD-DBM is supplied for laboratory research use only and is not approved for human or veterinary use. No conclusions can be drawn regarding safety or effects in humans.

Background: Wnt/β-Catenin Signaling in the Hair Follicle

The Wnt/β-catenin pathway has been implicated in hair follicle development and in hair regeneration in adult animals [1]. Several mouse studies established its role:

  • Follicle initiation: Expressing Dickkopf 1, a potent inhibitor of WNT action, in the skin of transgenic mice caused a complete failure of hair follicle placode formation, indicating that WNT signaling is required to initiate follicle development [2].
  • De novo follicle formation: Mice expressing a stabilized β-catenin under an epidermal promoter underwent a process resembling de novo hair morphogenesis, and the new follicles formed sebaceous glands and dermal papillae [3].
  • Regeneration after wounding: In genetically normal adult mice, hair follicles form de novo after wounding, a process known as wound-induced hair neogenesis (WIHN). Inhibiting Wnt signaling after re-epithelialization abolished this process, whereas overexpressing a Wnt ligand in the epidermis increased the number of regenerated follicles [4].

These findings make the Wnt/β-catenin pathway a central focus of research on hair-follicle development and regeneration.

CXXC5: A Negative Regulator of the Pathway

CXXC-type zinc finger protein 5 (CXXC5) is a negative-feedback regulator of the Wnt/β-catenin pathway. Its expression is induced by Wnt/β-catenin signaling, and it suppresses the pathway through Wnt-dependent binding to the Dishevelled (Dvl) protein [5][6].

The role of CXXC5 has been examined in several tissues. CXXC5-deficient mice showed elevated bone mineral density without severe developmental abnormalities [5], and accelerated cutaneous wound healing with enhanced keratin 14 and collagen synthesis [6].

In hair-follicle research, CXXC5-deficient (CXXC5-/-) mice displayed accelerated hair regrowth. The inhibitory effects of CXXC5 on alkaline phosphatase activity and cell proliferation were demonstrated in cultured human hair follicle dermal papilla cells [1].

PTD-DBM and Its Proposed Mechanism

PTD-DBM stands for protein transduction domain-fused Dishevelled-binding motif. It was developed as a competitor peptide that blocks the interaction between CXXC5 and Dishevelled [6][7].

By disrupting this negative-feedback loop, PTD-DBM activated β-catenin and collagen production in cultured cells [6]. In the primary hair-follicle study, disrupting the CXXC5–Dishevelled interaction with the competitor peptide activated the Wnt/β-catenin pathway and accelerated hair regrowth and wound-induced hair follicle neogenesis in mice [1].

Key Points From the Research

The published findings on PTD-DBM can be summarized in three points.

Target interaction:
PTD-DBM blocks the binding of CXXC5 to Dishevelled [1][6].

Pathway:
Because CXXC5 is a negative-feedback regulator, blocking its interaction with Dishevelled activates Wnt/β-catenin signaling in cell and mouse models [1][5][6].

Models studied:
PTD-DBM has been examined in mouse models of hair regrowth and wound-induced hair neogenesis [1], cutaneous wound healing [6] and prostaglandin D2-associated suppression of hair growth [7].

Further Mouse-Model Studies

Valproic acid, a glycogen synthase kinase 3β (GSK3β) inhibitor that activates the Wnt/β-catenin pathway, has been used alongside CXXC5 deficiency and PTD-DBM in these studies. Valproic acid further induced hair regrowth in CXXC5-/- mice [1], and co-treatment of skin wounds with PTD-DBM and valproic acid synergistically accelerated cutaneous wound healing in mice [6].

A 2023 study examined prostaglandin D2 (PGD2), a lipid mediator associated with suppressed hair growth. In mouse models, the effect of PGD2 was reversed by CXXC5 knockout or by PTD-DBM, and suppression of neogenic hair growth by PGD2 in the WIHN model was also overcome by PTD-DBM or CXXC5 knockout. The same study reported that CXXC5 mediates dihydrotestosterone (DHT)-induced effects through PGD2, and that these effects were alleviated by inhibiting both GSK-3β and CXXC5 [7].

Open Questions

Several questions remain open in the published research:

  • Mechanism: How CXXC5 and its interaction with Dishevelled are regulated across the hair-follicle cycle is still being explored.
  • Pathway cross-talk: The links between CXXC5, prostaglandin D2 and androgen signaling described in mouse models need further study [7].
  • Model scope: Published PTD-DBM data come from cultured cells and mouse models, and further research is needed before broader conclusions can be drawn.
  • Regulatory status: PTD-DBM is not approved for human or veterinary use.

For these reasons, PTD-DBM is best described as a compound for laboratory research.

Frequently Asked Questions

  • What is PTD-DBM?
    PTD-DBM (protein transduction domain-fused Dishevelled-binding motif) is a synthetic competitor peptide that blocks the interaction between CXXC5 and Dishevelled, which activates Wnt/β-catenin signaling in laboratory models [6].
  • What is CXXC5?
    CXXC5 is a zinc finger protein that acts as a negative-feedback regulator of the Wnt/β-catenin pathway by binding to Dishevelled [5].
  • Which research models have been used?
    Published studies used cultured cells, including human hair follicle dermal papilla cells, and mouse models of hair regrowth, wound-induced hair neogenesis and cutaneous wound healing [1][6][7].
  • Where is PTD-DBM available for research?
    PTD-DBM for laboratory research is available from PowerPeptides.com, which provides information on purity testing and handling. It is supplied for laboratory research use only.

Summary

The Wnt/β-catenin pathway is central to hair-follicle development and regeneration in mouse models. CXXC5 limits this pathway by binding Dishevelled, and PTD-DBM was developed to block that interaction. Published studies report that PTD-DBM activates Wnt/β-catenin signaling and affects hair regrowth, wound-induced hair neogenesis and wound healing in mice.

Product information, including purity and handling details, is available for PTD-DBM at PowerPeptides.com.

Disclaimer: PTD-DBM is a research-use-only peptide not approved for human or veterinary use. This overview summarizes published laboratory research only.

References

  1. Lee SH, Seo SH, Lee DH, Pi LQ, Lee WS, Choi KY. Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. J Invest Dermatol. 2017;137(11):2260–2269. doi:10.1016/j.jid.2017.04.038 · PMID 28595998

  2. Andl T, Reddy ST, Gaddapara T, Millar SE. WNT signals are required for the initiation of hair follicle development. Dev Cell. 2002;2(5):643–653. doi:10.1016/s1534-5807(02)00167-3 · PMID 12015971

  3. Gat U, DasGupta R, Degenstein L, Fuchs E. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell. 1998;95(5):605–614. doi:10.1016/s0092-8674(00)81631-1 · PMID 9845363

  4. Ito M, Yang Z, Andl T, Cui C, Kim N, Millar SE, et al. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature. 2007;447(7142):316–320. doi:10.1038/nature05766 · PMID 17507982

  5. Kim HY, Yoon JY, Yun JH, Cho KW, Lee SH, Rhee YM, et al. CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation. Cell Death Differ. 2015;22(6):912–920. doi:10.1038/cdd.2014.238 · PMID 25633194

  6. Lee SH, Kim MY, Kim HY, Lee YM, Kim H, Nam KA, et al. The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. J Exp Med. 2015;212(7):1061–1080. doi:10.1084/jem.20141601 · PMID 26056233

  7. Ryu YC, Park J, Kim YR, Choi S, Kim GU, Kim E, et al. CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2. Cells. 2023;12(4):555. doi:10.3390/cells12040555 · PMID 36831222

Read more about peptides